| P2093 | author name string | D M Geddes | |
| P2860 | cites work | Once daily inhalation of budesonide in the treatment of chronic asthma: a clinical comparison | Q69898766 |
| | Comparison of budesonide and beclomethasone dipropionate in patients with severe chronic asthma: assessment of relative prednisolone-sparing effects | Q69899158 |
| | Growth retardation in asthmatic children treated with inhaled beclomethasone dipropionate | Q69910906 |
| | Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma | Q69999565 |
| | Assessment of systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover | Q70212935 |
| | Comparison of twice daily administration of a new corticosteroid budesonide with beclomethasone dipropionate four times daily in the treatment of chronic asthma | Q70217919 |
| | Comparison of a new corticosteroid aerosol, budesonide, with beclomethasone dipropionate in the treatment of chronic asthma | Q70382023 |
| | Possible association between beclomethasone diproprionate aerosol and cataracts | Q71350562 |
| | Comparison between inhaled and oral corticosteroids in patients with chronic asthma | Q72054458 |
| | Topical and systemic glucocorticoid potencies of budesonide, beclomethasone dipropionate and prednisolone in man | Q72054486 |
| | High-dose beclomethasone inhaler in the treatment of asthma | Q72544382 |
| | Bone turnover during high dose inhaled corticosteroid treatment | Q28316066 |
| | Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. | Q34290463 |
| | Purpura and dermal thinning associated with high dose inhaled corticosteroids | Q34652477 |
| | Asthma treatment with a new corticosteroid aerosol, budesonide, administered twice daily by spacer inhaler | Q35116777 |
| | Growth of asthmatic children during treatment with budesonide: a double blind trial | Q35180079 |
| | Beclomethasone inhalation decreases serum osteocalcin concentrations | Q35185075 |
| | Steroid aerosols and cataract formation | Q35714930 |
| | Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 micrograms/day) and budesonide (1600 micrograms/day), for chronic asthma | Q36160131 |
| | Effect of high dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects | Q36175075 |
| | Response of patients receiving high dose beclomethasone dipropionate | Q36432135 |
| | A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma | Q40757560 |
| | Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality | Q41121522 |
| | Comparison of budesonide and beclomethasone dipropionate for treatment of asthma | Q42157517 |
| | Methodological aspects on clinical trials with inhaled corticosteroids: results of two comparisons between two steroid aerosols in patients with asthma | Q42261561 |
| | Mania triggered by a steroid nasal spray in a patient with stable bipolar disorder | Q42694317 |
| | Steroid aerosols and cataract formation | Q42878404 |
| | Inhaled corticosteroids, bone formation, and osteocalcin | Q43536167 |
| | Inhaled beclomethasone and oral candidiasis | Q43833531 |
| | The relationship of nonspecific airway responsiveness and atopy to the rate of decline of lung function. The Normative Aging Study | Q44275897 |
| | Comparison of dose-response effects of inhaled beclomethasone dipropionate and budesonide in the management of asthma | Q44508643 |
| | Inhaled corticosteroids, bone formation, and osteocalcin | Q45258451 |
| | Screening for hypothalamo-pituitary-adrenal axis suppression in asthmatics taking high dose inhaled corticosteroids | Q48631511 |
| | Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids | Q48631524 |
| | Safety of 1 year of treatment with budesonide in young children with asthma. | Q51615967 |
| | Effect of high-dose inhaled budesonide on calcium and phosphate metabolism and the risk of osteoporosis. | Q51625098 |
| | High dose nebulized steroid in the treatment of chronic steroid-dependent asthma | Q54066274 |
| | Glucocorticoids and asthma. Studies of resistance and systemic effects of glucocorticoids. | Q54482131 |
| | Adrenal function in children with bronchial asthma treated with beclomethasone dipropionate or budesonide | Q57638496 |
| | A three- to five-year follow-up of the use of the aerosol steroid, beclomethasone dipropionate, in childhood asthma | Q67404852 |
| | Urine cortisol excretion in children treated with high doses of inhaled corticosteroids: a comparison of budesonide and beclomethasone | Q67929246 |
| | Effect of inhaled corticosteroid on bone density in asthmatic patients: a pilot study | Q67938274 |
| | A double-blind dose-response study of budesonide by inhalation in patients with bronchial asthma | Q68142450 |
| | A comparison of inhaled budesonide and beclomethasone dipropionate in childhood asthma | Q68187244 |
| | Posterior subcapsular cataracts associated with nasal or inhalation corticosteroids | Q68765188 |
| | Beclomethasone dipropionate and oropharyngeal candidiasis | Q69356805 |
| | Extrapulmonary effects of maintenance corticosteroid therapy with alternate-day prednisone and inhaled beclomethasone in children with chronic asthma | Q69425464 |
| | Adrenocortical function in children on high-dose steroid aerosol therapy. Results of serum cortisol, ACTH stimulation test and 24 hour urinary free cortical excretion | Q69462299 |
| | Bioequivalent doses of budesonide and prednisone in moderate and severe asthma | Q69550545 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 404-407 | |
| P577 | publication date | 1992-06-01 | |
| P1433 | published in | Thorax | Q7796158 |
| P1476 | title | Inhaled corticosteroids: benefits and risks | |
| P478 | volume | 47 | |